Hold Lupin, target price Rs 1015: ICICI Direct
Lupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 42043.22 Crore) operating in Pharmaceuticals sector.

Lupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 42043.22 Crore) operating in Pharmaceuticals sector.
Lupin Ltd. key Products/Revenue Segments include Pharmaceuticals, Export Incentives, Other Operating Revenue and Other Services for the year ending 31-Mar-2021.
Financials
For the quarter ended 30-09-2021, the company reported a Consolidated Total Income of Rs 4164.14 Crore, down -3.11 % from last quarter Total Income of Rs 4298.02 Crore and up 7.88 % from last year same quarter Total Income of Rs 3859.96 Crore. Company reported net profit after tax of Rs -2094.89 Crore in latest quarter.
Investment Rationale
The brokerage maintains HOLD as key addressable issues such as progress on the margins front, pricing pressure and competition in key US products besides pending resolution at other key plants still continue to weigh
Promoter/FII Holdings
Promoters held 46.83 per cent stake in the company as of 30-Sep-2021, while FIIs owned 15.66 per cent, DIIs 24.46 per cent.
Download ET Markets APP